Resistell News:

The imperative of ultra-rapid Antibiotic Susceptibility Testing

The imperative of ultra-rapid Antibiotic Susceptibility Testing
Resistell News:

The imperative of ultra-rapid Antibiotic Susceptibility Testing

Antibiotic treatments are often preemptively initiated without knowing the antibiotic resistance profile of the causative pathogen. This leads to potentially inappropriate therapies. Ultra-rapid Antibiotic Susceptibility Testing (AST) is key in identifying the effective antibiotics, and here are compelling reasons for healthcare providers to prioritize it.

More
The imperative of ultra-rapid Antibiotic Susceptibility Testing

Latest news

Resistell technology in Frontiers in Mechanical Engineering
29th July 2020

Resistell technology in Frontiers in Mechanical Engineering

Nanomechanical Sensors as a Tool for Bacteria Detection and Antibiotic Susceptibility Testing
More
Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC
3rd July 2020

Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC

Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.
More
Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection
19th June 2020

Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection

We invite you to study the "Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection" published in TrAC Trends in Analytical Chemistry, Volume 127, June 2020 by Jiri Dietvorst, Luïsa Vilaplana, Naroa Uria, Maria-Pilar Marco, Xavier Muñoz-Berbel.
More
Top100 Startup 2020 public voting has began, vote for Resistell
8th June 2020

Top100 Startup 2020 public voting has began, vote for Resistell

Resistell, EPFL spinoff, located on the brand new 5th floor in Muttenz, is developing world’s fastest antibiotic susceptibility test to help the physicians around the world save patients lives. Our solution is needed more than ever in the context of global pandemics. Last year we have secured CHF 3.5 M in equity financing and won Innosuisse and Eurostars grants. Our core team counts 10 people and we expect to grow further in the next months. Last year we were 34th and among top 5 newcomers on the Top 100 Swiss Startups list. Help us climb faster to the top! Vote now!
More
Resistell rapid AST in Nature Reviews Microbiology
11th May 2020

Resistell rapid AST in Nature Reviews Microbiology

Nature Reviews Microbiology: Innovative and rapid antimicrobial susceptibility testing systems
More